Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7949 results

Sort By:

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Study ID: NCT06049420
Start Date: 2024-04
End Date: 2025-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

95

Intervention / Treatment

Lifestyle counseling and coaching

Sponsor

West Virginia School of Osteopathic Medicine

Source: clinicaltrials.gov

Share:
Add to list

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

Study ID: NCT05204862
Start Date: 2021-12-02
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

240

Intervention / Treatment

TU2218

Anti-PD-1 antibody

Sponsor

TiumBio Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Study ID: NCT05798780
Start Date: 2023-04-06
End Date: 2026-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

ENHANCE Intervention - Exercise and Nutrition

ENHANCE Intervention - Nutrition Only

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Study ID: NCT05889091
Start Date: 2023-05-16
End Date: 2026-05-16
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

HRQOL instruments

LENT SOMA instrument

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Study ID: NCT05733689
Start Date: 2025-06
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

ctDNA Blood Test

Nice

FOLFOX

FOLFIRI

FOLFIRINOX

PACLITAXEL with or without CARBOPLATIN

DOCETAXEL and IRINOTECAN (alone or combined)

NIVOLUMAB (alone or when added to a regimen above)

PEMBROLIZUMAB (alone or when added to a regimen above)

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Study ID: NCT06480591
Start Date: 2025-01-21
End Date: 2026-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

Blood Draw

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

High Dose Omeprazole in Patients With Pancreatic Cancer

Study ID: NCT04930991
Start Date: 2021-09-07
End Date: 2026-06
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

60

Intervention / Treatment

Omeprazole

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

Pleuroscopy First Versus Thoracentesis First in Patients with Suspected Malignant Pleural Effusions

Study ID: NCT06892691
Start Date: 2025-03
End Date: 2026-09-17
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

98

Intervention / Treatment

Pleuroscopy first

Thoracentesis first

Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

SW-682 in Advanced Solid Tumors

Study ID: NCT06251310
Start Date: 2024-07-30
End Date: 2030-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

186

Intervention / Treatment

SW-682

Combination Therapy

Sponsor

SpringWorks Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

Study ID: NCT05873712
Start Date: 2023-07-28
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

Fludarabine

Leukapheresis

Lisocabtagene Maraleucel

Lymph Node Biopsy

Positron Emission Tomography

Zanubrutinib

Sponsor

Aseel Alsouqi

Source: clinicaltrials.gov

Share:
Add to list